Research memoSmith & Nephew plc (SN.L) · LSEMemo of October 20, 2026By Olivier Lachance

Smith+Nephew stock forecast 2027–2029

MyStockButler's October 2026 analysis: Smith+Nephew's probability-weighted price reaches 1,954.18 GBp in October 2029, a 90% return including dividends. It hinges on LANDMARK, CORI and other launches generating repeat procedures.

1,077.5
Share price today, GBp
1954.18 (+90 %)
Weighted scenario, October 2029
6.3%
Real free cash flow yield
12.0x
P/E, next 12 months
Read the full Smith+Nephew memoYour first S&P 500 report is free · no card
Every number traced to Smith+Nephew's filings8 chapters · 17,344 words179 sources cited

Where could Smith+Nephew's shares go?

The probability-weighted price is 1,478.35 GBp in October 2027, a 40% return including dividends. It reaches 1,699.33 GBp in October 2028, a 63% return. By October 2029, it reaches 1,954.18 GBp, a 90% return.

The 2029 bear case is 949.17 GBp. The bull case is 3,226.90 GBp, versus 1,077.50 GBp today. The forecast assigns 30% to the bear case, 50% to the base case and 20% to the bull case.

Smith+Nephew share price scenarios for October 2029: bear 949.17p, base 2048.11p, bull 3226.90p
What the shares could be worthGBp per SN.L share at each date; in brackets the return since today's 1077.50, dividends included
CaseProbabilityOctober 2027October 2028October 2029
Bear30 %1114.12 (+6 %)1036.14 (+1 %)949.17 (-4 %)
Base50 %1506.81 (+43 %)1767.13 (+70 %)2048.11 (+99 %)
Bull20 %1953.55 (+84 %)2524.60 (+140 %)3226.90 (+209 %)
Weighted100 %1478.35 (+40 %)1699.33 (+63 %)1954.18 (+90 %)

What this means. The weighted row is the average value after giving each case more or less influence based on its probability, so it is not a fourth outcome.

What has to go right for Smith+Nephew?

The bear case gives $870 million in the first year and remains near that level thereafter. Its margin falls to 12.7% as weak US knees, tenders and reimbursement pressure persist. The bull case reaches $1,312 million, with margin reaching 16.5%, if LANDMARK, CORI and other launches generate repeat procedures.

How much cash does Smith+Nephew really make?

Cash from operations reached $1,285 million in 2025. Capital spending was $433 million. Lease payments were $50 million, leaving $802 million of free cash flow on a consistent basis before further shareholder-cost adjustments.

Follow the money: real free cash flowUS$ millions
20252024202320222021
Cash from operations1,285987608468877
− Capital spending433381427358408
− Lease payments5055525459
= Free cash flow80255112956410
− Stock pay4340394041
= Real free cash flow7595119016369

What does an investor pay for Smith+Nephew?

Free cash flow is therefore the better cross-check. The reported free cash flow yield is 6.7%, but that is not the same as the 2.7% dividend yield: the board can use cash for debt, acquisitions, instruments, inventory or buybacks. The table shows the valuation measures that investors are paying for.

What an investor pays today£ millions; per share in pence
Today (Oct 20, 2026)
Share price1,077.5
P/E, last 12 months (calculated)19.5x
P/E, next 12 months (calculated)12.0x
EV / revenue, last 12 months (calculated)2.4x
Free cash flow yield (calculated)6.7%
Real free cash flow yield (calculated)6.3%

What this means. The enterprise value is higher than the market value because it includes the company’s debt after subtracting its cash.

From the full memo · 1. The business

Smith+Nephew makes the implants, surgical tools and wound treatments that help clinicians repair or replace damaged parts of the body. Its business earns revenue when healthcare providers buy those products, but its cash often leaves long before treatment creates a sale.

Continue reading, free
Your first S&P 500 report is free · no card

Where these numbers come from

More on Smith+Nephew

Smith+Nephew dividend

Its rivals

Zimmer Biomet (ZBH)Stryker (SYK)Johnson & Johnson (JNJ)Solventum (SOLV)

Browse

All stocksFTSE 100 companiesCompanies SBloomberg Terminal alternatives
The full Smith+Nephew memoYour first S&P 500 report is free
Read it